These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37986663)

  • 1. Advances in device-based treatment of heart failure with preserved ejection fraction: evidence from clinical trials.
    Wu Y; Song M; Wu M; Lin L
    ESC Heart Fail; 2024 Feb; 11(1):13-27. PubMed ID: 37986663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device Therapy for Heart Failure with Preserved Ejection Fraction.
    Salah HM; Levin AP; Fudim M
    Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Rosalia L; Ozturk C; Shoar S; Fan Y; Malone G; Cheema FH; Conway C; Byrne RA; Duffy GP; Malone A; Roche ET; Hameed A
    JACC Basic Transl Sci; 2021; 6(9-10):772-795. PubMed ID: 34754993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
    Burlacu A; Simion P; Nistor I; Covic A; Tinica G
    Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction.
    Zhang Z; Xiao Y; Dai Y; Lin Q; Liu Q
    Heart Fail Rev; 2024 Mar; 29(2):417-430. PubMed ID: 37940727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Kumar HU; Nearing BD; Mittal S; Premchand RK; Libbus I; DiCarlo LA; Amurthur B; KenKnight BH; Anand IS; Verrier RL
    Int J Cardiol; 2023 Jun; 381():37-44. PubMed ID: 36934987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
    Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
    ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
    Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
    Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?
    Gupta A; Bailey SR
    Curr Cardiol Rep; 2018 Aug; 20(10):85. PubMed ID: 30112586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of inflammation in heart failure with preserved ejection fraction].
    Zhang Q; Chen YE; Zhu XX; Wang X; Qu AJ
    Sheng Li Xue Bao; 2023 Jun; 75(3):390-402. PubMed ID: 37340648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
    Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
    JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
    Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
    Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: A comprehensive assessment by echocardiography.
    Liu S; Guan Z; Zheng X; Meng P; Wang Y; Li Y; Zhang Y; Yang J; Jia D; Ma C
    Int J Cardiol; 2018 Apr; 257():177-181. PubMed ID: 29506691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Rate-Induced Myocardial Ca
    Silverman DN; Rambod M; Lustgarten DL; Lobel R; LeWinter MM; Meyer M
    J Am Heart Assoc; 2020 Sep; 9(17):e017215. PubMed ID: 32856526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy.
    Clemmer JS; Pruett WA
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H597-H607. PubMed ID: 35984764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.